ERK-dependent induction of the immediate-early gene Egr1 and the late gene Gpr50 contribute to two distinct phases of PACAP Gs-GPCR signaling for neuritogenesis

J Neuroendocrinol. 2022 Sep;34(9):e13182. doi: 10.1111/jne.13182. Epub 2022 Jul 16.

Abstract

Gs-coupled GPCR-stimulated neuritogenesis in PC12 and NS-1 - cells depends on activation of the MAP kinase ERK. Here, we examine changes in ERK activation (phosphorylation), and the time course of ERK-dependent gene induction, to seek transcriptional determinants for this process. Quenching of ERK activation by inhibition of MEK with U0126 at any time point for at least 24 h following addition of PACAP resulted in arrest of neurite formation. Changes in the transcriptome profile throughout this time period revealed at least two phases of gene induction: an early phase dominated by induction of immediate-early genes, and a later phase of gene induction after 4-6 h of exposure to PACAP with persistent elevation of phospho-ERK levels. Genes induced by PACAP in both phases consisted in those whose induction was dependent on ERK (i.e., blocked by U0126), and some whose induction was blocked by the protein kinase A inhibitor H89. ERK-dependent "late gene" transcripts included Gpr50, implicated earlier in facilitation of NGF-induced neurite formation in NS-1 cells. Gpr50 induction by PACAP, but not NGF, was dependent on the guanine nucleotide exchange factor RapGEF2, which has been shown to be required for PACAP-induced neuritogenesis in NS-1 cells. Expression of a Gpr50-directed shRNA lowered basal levels of Gpr50 mRNA and attenuated Gpr50 mRNA and GPR50 protein induction by PACAP, with a corresponding attenuation of PACAP-induced neuritogenesis. Gs-GPCR-stimulated neuritogenesis first requires immediate-early gene induction, including that of Egr1 (Zif268/NGF1A/Krox24) as previously reported. This early phase of gene induction, however, is insufficient to maintain the neuritogenic process without ERK-dependent induction of additional late genes, including Gpr50, upon continuous exposure to neurotrophic neuropeptide. Early (Egr1) and late (Gpr50) gene induction by NGF, like that for PACAP, was inhibited by U0126, but was independent of RapGEF2, confirming distinct modes of ERK activation by Gs-coupled GPCRs and neurotrophic tyrosine receptor kinases, converging on a final common ERK-dependent signaling pathway for neuritogenesis.

Keywords: ERK; Egr1; Gpr50; RapGEF2; cyclic AMP.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Benzoates
  • Butadienes
  • Early Growth Response Protein 1 / genetics
  • Genes, Immediate-Early*
  • Guanine Nucleotide Exchange Factors / genetics
  • Guanine Nucleotide Exchange Factors / metabolism
  • Mitogen-Activated Protein Kinase Kinases / genetics
  • Nitriles
  • PC12 Cells
  • Pituitary Adenylate Cyclase-Activating Polypeptide* / genetics
  • Pituitary Adenylate Cyclase-Activating Polypeptide* / metabolism
  • Pituitary Adenylate Cyclase-Activating Polypeptide* / pharmacology
  • RNA, Messenger / metabolism
  • RNA, Small Interfering
  • Rats

Substances

  • Benzoates
  • Butadienes
  • Early Growth Response Protein 1
  • Egr1 protein, rat
  • Guanine Nucleotide Exchange Factors
  • Nitriles
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • RNA, Messenger
  • RNA, Small Interfering
  • U 0126
  • 4-(2-(4-isopropylbenzamido)ethoxy)benzoic acid
  • Mitogen-Activated Protein Kinase Kinases